Mevissen M, Häussler M, Lerchl A, Löscher W
Department of Pharmacology, Toxicology, and Pharmacology, School of Veterinary Medicine, Hannover, Germany.
J Toxicol Environ Health A. 1998 Mar 13;53(5):401-18. doi: 10.1080/009841098159259.
In view of the methodological problems of epidemiological studies on associations between residential and occupational exposures to 50/60-Hz magnetic fields (MF) and increased incidence of cancers, laboratory studies are necessary to determine if 50/60-Hz MF can affect cancer development or growth. Recently, it was reported that alternating (50-Hz) MF of low flux density (100 microT) increase tumor growth and progression in a model of breast cancer in female rats in which mammary tumors were induced by the chemical carcinogen 7,12-dimethylbenz[a]anthracene (DMBA). The objective of the present study was to determine if a replicate experiment carried out in the same laboratory under the same experimental conditions yields a significant increase in tumor development and growth of similar magnitude. For the MF experiment, a group of 99 female Sprague-Dawley rats was exposed to a homogeneous horizontally polarized MF for 24 h/d (minus time for weighing, tumor palpation, cage cleaning, cage rotation), 7 d/wk; another group of 99 rats was sham exposed. DMBA was administered intragastrically at a dose of 5 mg/rat at the first day of exposure and at weekly intervals thereafter up to a total dose of 20 mg/rat. Duration of MF or sham exposure was 91 d. In both MF-exposed and sham-exposed rats, the first tumors could be recorded 6 wk after the initial DMBA application. At 9 wk after DMBA application, the group of MF-exposed rats exhibited significantly more animals with tumors than the sham-exposed group. This significant difference in the rate of tumor development was observed throughout the subsequent period of exposure. After autopsy, the incidence of macroscopically visible mammary tumors was 62% in controls, but 83% in MF-exposed rats, with the 35% difference between groups being statistically significant. Data substantiate that long-term exposure of DMBA-treated female Sprague-Dawley rats in an alternating MF of low flux density promotes the development and growth of mammary tumors, thus indicating that MF exposure exerts tumor-promoting and/or copromoting effects. Furthermore, the data show that the effects of MF exposure in the DMBA breast cancer model are reproducible if the same experiment is repeated in the same laboratory.
鉴于关于居住和职业暴露于50/60赫兹磁场(MF)与癌症发病率增加之间关联的流行病学研究存在方法学问题,有必要进行实验室研究以确定50/60赫兹MF是否会影响癌症的发生或发展。最近有报道称,低通量密度(100微特斯拉)的交变(50赫兹)MF会加速雌性大鼠乳腺癌模型中的肿瘤生长和进展,该模型中的乳腺肿瘤由化学致癌物7,12 - 二甲基苯并[a]蒽(DMBA)诱导产生。本研究的目的是确定在同一实验室相同实验条件下进行的重复实验是否会使肿瘤的发生和生长出现类似程度的显著增加。对于MF实验,将一组99只雌性斯普拉格 - 道利大鼠每天暴露于均匀的水平极化MF 24小时(减去称重、触诊肿瘤、清洁笼子、转动笼子的时间),每周7天;另一组99只大鼠进行假暴露。在暴露的第一天,以5毫克/只大鼠的剂量通过胃内给药DMBA,此后每周给药一次,直至总剂量达到20毫克/只大鼠。MF暴露或假暴露的持续时间为91天。在MF暴露组和假暴露组大鼠中,首次记录到肿瘤是在最初给予DMBA后的6周。在给予DMBA后的9周,MF暴露组出现肿瘤的动物数量明显多于假暴露组。在随后的整个暴露期间都观察到了肿瘤发生率的显著差异。尸检后,对照组中肉眼可见的乳腺肿瘤发生率为62%,而MF暴露组为83%,两组之间35%的差异具有统计学意义。数据证实,长期将经DMBA处理的雌性斯普拉格 - 道利大鼠暴露于低通量密度的交变MF中会促进乳腺肿瘤的发生和生长,这表明MF暴露具有肿瘤促进和/或协同促进作用。此外,数据表明,如果在同一实验室重复相同的实验,MF暴露在DMBA乳腺癌模型中的效应是可重复的。